MRNAON
MRNAON is the Ondo tokenized version of Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical needs, including infectious diseases, cancer immunology, rare conditions, cardiovascular ailments, and autoimmune disorders, with operations spanning the United States, Europe, and other global markets. The company's diverse product pipeline encompasses various vaccine candidates: those for respiratory illnesses, latent viral infections and public health threats. Additionally, Moderna is advancing systemic secreted and cell surface-targeted therapeutics, an array of cancer vaccines (including personalized, KRAS, and checkpoint varieties), intratumoral immuno-oncology products, localized regenerative treatments, systemic intracellular medicines, and inhaled pulmonary solutions.
Име MRNAON
Ранг No.
Тржишна капитализација $0.00
Потпуно разводњена тржишна капитализација $0.00
Тржишни удео %
Обим трговања/Тржишна капитализација (24H) 0
Циркулишућа понуда --
Максимална понуда 0
Укупна понуда --
Стопа циркулације %
Датум издавања --
Цена по којој је средство први пут издато --
Историјски максимум ,
Најнижа цена ,
Јавни блокчејн MRNAON
Увод MRNAON is the Ondo tokenized version of Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical needs, including infectious diseases, cancer immunology, rare conditions, cardiovascular ailments, and autoimmune disorders, with operations spanning the United States, Europe, and other global markets. The company's diverse product pipeline encompasses various vaccine candidates: those for respiratory illnesses, latent viral infections and public health threats. Additionally, Moderna is advancing systemic secreted and cell surface-targeted therapeutics, an array of cancer vaccines (including personalized, KRAS, and checkpoint varieties), intratumoral immuno-oncology products, localized regenerative treatments, systemic intracellular medicines, and inhaled pulmonary solutions.
Сектор
- common.mc-trade-zone-xStocks
Друштвене мреже
Анализа тока средстава
|
Купите(MRNAON) |
Продајте(MRNAON) |
Нето прилив |
| Велико |
0.000 |
0.000 |
0.000 |
| Средње |
0.000 |
0.000 |
0.000 |
| Мало |
1.259K |
637.251 |
621.936 |
| Укупно |
1.259K |
637.251 |
621.936 |
Одрицање од одговорности: Подаци су обезбеђени од стране и не треба да се сматрају инвестиционим саветом.